Cargando…
Targeting autophagy in pancreatic cancer: The cancer stem cell perspective
Pancreatic cancer is currently the seventh leading cause of cancer-related deaths worldwide, with the estimated death toll approaching half a million annually. Pancreatic ductal adenocarcinoma (PDAC) is the most common (>90% of cases) and most aggressive form of pancreatic cancer, with extremely...
Autores principales: | Troumpoukis, Dimitrios, Papadimitropoulou, Adriana, Charalampous, Chrysanthi, Kogionou, Paraskevi, Palamaris, Kostas, Sarantis, Panagiotis, Serafimidis, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730023/ https://www.ncbi.nlm.nih.gov/pubmed/36505808 http://dx.doi.org/10.3389/fonc.2022.1049436 |
Ejemplares similares
-
Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
por: Poulia, Kalliopi Anna, et al.
Publicado: (2020) -
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020) -
Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021) -
Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020) -
Molecular Pathways Controlling Autophagy in Pancreatic Cancer
por: New, Maria, et al.
Publicado: (2017)